Using our proprietary Enhanced Design and Combine (EDC) chemistry platform, we are developing an emerging portfolio of novel designer immunotherapies for the treatment of cancer and autoimmune diseases.
Klybeckstrasse 191, 4057 Basel, Switzerland
Alloy Therapeutics is a biotechnology ecosystem company democratizing access to tools, technologies, and services for discovering and developing therapeutic biologics across six modalities, including antibodies, TCRs, genetic medicines, peptides, cell therapy, and drug delivery.
Peptone, founded in 2018, specialises in the development of novel therapeutics against Intrinsically disordered proteins (IDP) for cancer and inflammatory diseases, to name a few. Peptone's approach stems from experimental biophysics, supercomputing, and machine learning.
plusbiome AG is a Swiss startup company working at the interface of digital health and the microbiome. We design and market customised probiotics that truly support customers and their well-being,. Customers also profit from accompanying Apps.